Mirador Therapeutics
Niels Vande Casteele is an experienced professional in the field of clinical pharmacology and translational medicine, currently serving as Executive Director at Mirador Therapeutics. Previously, Niels founded and presided over AcelaBio, demonstrating entrepreneurial leadership. Additionally, Niels gained valuable research experience as a Postdoctoral Fellow at the Research Foundation Flanders - FWO.
This person is not in any teams
This person is not in any offices
Mirador Therapeutics
Mirador is a next-generation precision medicine company focused on immunology and inflammation. The company’s Mirador360 TM precision development engine leverages the latest advances in human genetics and cutting-edge data science to rapidly advance new precision medicines for patients living with chronic immune-mediated inflammatory and fibrotic diseases. Launched in 2024, Mirador has raised over $400 million from leading life sciences investors and is based in San Diego, CA.